Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Oct 31, 2025 | (FY)Apr 30, 2025 | (Q6)Oct 31, 2024 | (FY)Apr 30, 2024 | (Q6)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q9)Jan 31, 2023 | (Q6)Oct 31, 2022 | (Q1)Jul 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -3.24%15.8M | 6.34%40.55M | -36.32%16.33M | -60.82%38.13M | -52.96%25.65M | -50.75%12.15M | 66.82%97.33M | 61.87%83.13M | 72.12%54.53M | 58.93%24.66M |
| Operating income | -3.24%15.8M | 6.34%40.55M | -36.32%16.33M | -60.82%38.13M | -52.96%25.65M | -50.75%12.15M | 66.82%97.33M | 61.87%83.13M | 72.12%54.53M | 58.93%24.66M |
| Cost of sales | 5.42%-15.09M | -3.81%-38.83M | 36.48%-15.96M | 60.78%-37.41M | 52.70%-25.12M | 50.50%-11.92M | -69.43%-95.37M | -64.14%-81.43M | -73.76%-53.1M | -61.56%-24.09M |
| Operating expenses | 5.42%-15.09M | -3.81%-38.83M | 36.48%-15.96M | 60.78%-37.41M | 52.70%-25.12M | 50.50%-11.92M | -69.43%-95.37M | -64.14%-81.43M | -73.76%-53.1M | -61.56%-24.09M |
| Gross profit | 88.62%713K | 137.02%1.72M | -28.95%378K | -63.10%724K | -62.69%532K | -61.01%225K | -4.48%1.96M | -2.58%1.7M | 27.32%1.43M | -5.41%577K |
| Administrative expenses | -53.04%-8.17M | -51.21%-5.95M | -262.84%-5.34M | 80.13%-3.94M | 86.69%-1.47M | 83.95%-798K | -165.17%-19.82M | -144.71%-13.09M | -166.74%-11.06M | -288.66%-4.97M |
| Impairment and provision | ---- | 66.77%-1.88M | ---- | -37.08%-5.65M | ---- | ---- | 73.64%-4.12M | ---- | ---- | ---- |
| -Other impairment is provision | ---- | 66.77%-1.88M | ---- | -37.08%-5.65M | ---- | ---- | 73.64%-4.12M | ---- | ---- | ---- |
| Special items of operating profit | 1,208.46%38.81M | 108.87%226K | 187.73%2.97M | 73.23%-2.55M | -641.45%-3.38M | -207.71%-1.05M | -483.78%-9.51M | -825.19%-13.65M | 68.00%-456K | 461.71%973K |
| Operating profit | 1,669.75%31.35M | 48.39%-5.89M | 53.78%-2M | 63.77%-11.41M | 57.17%-4.32M | 52.62%-1.62M | -69.53%-31.49M | -1,351.71%-25.04M | -126.67%-10.09M | -264.71%-3.42M |
| Financing cost | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%-260K | 0.51%-196K | 0.00%-131K | 0.00%-66K |
| Earning before tax | 1,669.75%31.35M | 48.39%-5.89M | 53.78%-2M | 64.07%-11.41M | 57.72%-4.32M | 53.51%-1.62M | -68.57%-31.75M | -1,213.11%-25.24M | -123.05%-10.22M | -247.31%-3.49M |
| After-tax profit from continuing operations | 1,669.75%31.35M | 48.39%-5.89M | 53.78%-2M | 64.07%-11.41M | 57.72%-4.32M | 53.51%-1.62M | -69.08%-31.75M | -1,213.11%-25.24M | -123.05%-10.22M | -247.31%-3.49M |
| Earning after tax | 1,669.75%31.35M | 48.39%-5.89M | 53.78%-2M | 64.07%-11.41M | 57.72%-4.32M | 53.51%-1.62M | -69.08%-31.75M | -1,213.11%-25.24M | -123.05%-10.22M | -247.31%-3.49M |
| Profit attributable to shareholders | 1,669.75%31.35M | 48.39%-5.89M | 53.78%-2M | 64.07%-11.41M | 57.72%-4.32M | 53.51%-1.62M | -69.08%-31.75M | -1,213.11%-25.24M | -123.05%-10.22M | -247.31%-3.49M |
| Basic earnings per share | 1,670.37%0.1272 | 48.38%-0.0239 | 53.71%-0.0081 | 64.47%-0.0463 | 58.73%-0.0175 | 55.41%-0.0066 | -60.07%-0.1303 | -1,154.22%-0.1041 | -113.07%-0.0424 | -236.36%-0.0148 |
| Diluted earnings per share | 1,670.37%0.1272 | 48.38%-0.0239 | 53.71%-0.0081 | 64.47%-0.0463 | 58.73%-0.0175 | 55.41%-0.0066 | -60.07%-0.1303 | -1,154.22%-0.1041 | -113.07%-0.0424 | -236.36%-0.0148 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | -- |
| Auditor | -- | Zhongzheng Tianheng Certified Public Accountants Co., Ltd. | -- | PRIVATCO CPA LIMITED | -- | -- | Kaiyuan Shun Tak Certified Public Accountants Limited | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.